CalciMedica (CALC) EBITDA Margin: History & Chart

CalciMedica, Inc.(CALC)

Biotechnology · La Jolla, CA

$1.540.00 (0.00%)

Delayed quote: Oct 6, 2026, 9:51 AM EDT

About CalciMedica, Inc.

CalciMedica, Inc., a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequate therapies. The company's proprietary approach involves blocking calcium release-activated (CRAC) channels, a mechanism designed to modulate the immune system and protect against cellular and tissue damage in these severe conditions. Their primary experimental drug, Auxora, is an intravenously administered, proprietary CRAC channel inhibitor being developed for the treatment of acute pancreatitis, including its asparaginase-associated form, and acute kidney injury.

La Jolla, CA

15 employees

www.calcimedica.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: A. Rachel Leheny

View full financials

NAME	MARKET CAP	EBITDA MARGIN	TTM	3Y	5Y
CalciMedica, Inc. (CALC)	$4.85M	N/A	N/A	N/A	N/A
Bio Green Med Solution, Inc. (BGMS)vs ›	$4.80M	-1127.44%	-14514.89%	-11694.21%	-11694.21%
Lexaria Bioscience Corp. (LEXX)vs ›	$4.79M	-1670.57%	-1446.66%	-2067.25%	-1679.39%
Gelteq Limited Ordinary Shares (GELS)vs ›	$4.96M	-2579.35%	-2579.35%	-2089.74%	-2089.74%
Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs ›	$5.14M	N/A	N/A	N/A	N/A
Dermata Therapeutics, Inc. (DRMA)vs ›	$4.55M	N/A	N/A	N/A	N/A
Imunon, Inc. (IMNN)vs ›	$5.21M	-4837.99%	-4449.42%	-4104.15%	-4023.55%
Basel Medical Group Ltd Ordinary Shares (BMGL)vs ›	$5.24M	-8.85%	9.13%	18.32%	18.32%
CollPlant Biotechnologies Ltd. (CLGN)vs ›	$4.42M	-445.85%	-1797.00%	-2252.67%	-1514.30%
Ernexa Therapeutics Inc. (ERNA)vs ›	$4.41M	-2411.68%	-15920.55%	-15920.55%	-10610.40%

NAME

MARKET CAP

EBITDA MARGIN

TTM

CalciMedica, Inc. (CALC)

$4.85M

N/A

Bio Green Med Solution, Inc. (BGMS)vs ›

$4.80M

-1127.44%

-14514.89%

-11694.21%